Literature DB >> 12542987

The role of epinephrine in the treatment of anaphylaxis.

Anne K Ellis1, James H Day.   

Abstract

Epinephrine is the cornerstone of anaphylaxis management. Its administration should be immediate upon evidence of the occurrence of anaphylaxis. Delays in administration may be fatal. The most appropriate administration is 0.3 to 0.5 mL of 1:1000 dilution intramuscularly for adults and 0.01 mg/kg for children, given in the lateral thigh. Patients with known anaphylactic reactivity should be prescribed an epinephrine auto-injector to be carried at all times for treatment of potential recurrences. Education of the patient or parent regarding the proper use of this tool is paramount.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542987     DOI: 10.1007/s11882-003-0004-y

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.919


  38 in total

Review 1.  Anaphylaxis.

Authors:  T P Atkinson; M A Kaliner
Journal:  Med Clin North Am       Date:  1992-07       Impact factor: 5.456

Review 2.  Anaphylaxis.

Authors:  B S Bochner; L M Lichtenstein
Journal:  N Engl J Med       Date:  1991-06-20       Impact factor: 91.245

Review 3.  Anaphylaxis in children.

Authors:  L Kagy; M S Blaiss
Journal:  Pediatr Ann       Date:  1998-11       Impact factor: 1.132

Review 4.  Guidelines for the management of anaphylaxis in the emergency department.

Authors:  M Gavalas; A Sadana; S Metcalf
Journal:  J Accid Emerg Med       Date:  1998-03

5.  Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical?

Authors:  F E Simons; E S Chan; X Gu; K J Simons
Journal:  J Allergy Clin Immunol       Date:  2001-12       Impact factor: 10.793

6.  EpiPen Jr versus EpiPen in young children weighing 15 to 30 kg at risk for anaphylaxis.

Authors:  F Estelle R Simons; Xiaochen Gu; Norman A Silver; Keith J Simons
Journal:  J Allergy Clin Immunol       Date:  2002-01       Impact factor: 10.793

7.  Epinephrine absorption in children with a history of anaphylaxis.

Authors:  F E Simons; J R Roberts; X Gu; K J Simons
Journal:  J Allergy Clin Immunol       Date:  1998-01       Impact factor: 10.793

8.  First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen).

Authors:  M S Gold; R Sainsbury
Journal:  J Allergy Clin Immunol       Date:  2000-07       Impact factor: 10.793

9.  Systemic absorption of adrenaline after aerosol, eye-drop and subcutaneous administration to healthy volunteers.

Authors:  C Dahlöf; T Mellstrand; N Svedmyr
Journal:  Allergy       Date:  1987-04       Impact factor: 13.146

Review 10.  Beta-blocker therapy and the risk of anaphylaxis.

Authors:  J H Toogood
Journal:  CMAJ       Date:  1987-05-01       Impact factor: 8.262

View more
  6 in total

Review 1.  Adrenaline in the treatment of anaphylaxis: what is the evidence?

Authors:  Andrew P C McLean-Tooke; Claire A Bethune; Ann C Fay; Gavin P Spickett
Journal:  BMJ       Date:  2003-12-06

Review 2.  Outpatient Emergencies: Anaphylaxis.

Authors:  Scott P Commins
Journal:  Med Clin North Am       Date:  2017-03-02       Impact factor: 5.456

Review 3.  [Out-of-Hospital treatment of anaphylactoid reactions].

Authors:  A Walther; B W Böttiger
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

4.  Anaphylactic reaction to intravenous diclofenac.

Authors:  Ranju Singh; Deepak Bansal; Neha Baduni; Homay Vajifdar
Journal:  Indian J Crit Care Med       Date:  2011-01

5.  Anaphylaxis in Omani Patients: A Study from a Tertiary Care Center.

Authors:  Salem Al Tamemi; Yusra Al Lamki; Shafiq Ur-Rehman Naseem; Nabila Al Siyabi; Bushra Al Siyabi; Ibrahim Al-Zakwani
Journal:  Oman Med J       Date:  2022-01-31

6.  Diclofenac induced anaphylaxis: A case report from Nepal.

Authors:  Himal Bikram Bhattarai; Sangam Shah; Manish Uprety; Santosh Baniya; Gyabina Maharjan; Anshu Priya; Prabesh Bikram Singh; Ayusha Subedi
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.